Michael Finney

Michael Finney General Information

Description

Dr. Michael Finney serves as Board Member at Life Science Angels. He also serves as the Board Member of Orion Genomics. He also serves Managing Director of Finney Capital. Dr. Finney has been Acting Chief Executive Officer of Vaxart Inc. since July 2009. Dr. Finney serves as Chief Scientific Officer of MJ Bioworks Inc. Dr. Finney Co-founded MJ Research, Incorporated in 1987. He founded MJ Bioworks. He has experience with founding and managing start up companies. He served as Chief Scientific Officer of MJ Research Inc. He served as an Advisor of Vaxart Inc. He serves as Chairman of Sage Science, Inc. He serves as Director of Vaxart, Inc. He serves as Director of Orion Genomics LLC. He serves as a Director of WaveMark Inc. He served as a Director of PharmaSecure, Inc. He served as a Scientific Advisor of Orion Genomics LLC. Dr. Finney is the author of numerous scientific articles and holds 7 US patents. Dr. Finney completed postdoctoral work from the Harvard Medical School Department of Genetics at Massachusetts General Hospital from 1987 to 1990. Dr. Finney received an BA in Biochemical Sciences from Harvard University in 1980 and a Ph.D. in Biology from the Massachusetts Institute of Technology in 1987. Dr. Finney is an investor based in San Francisco. He was a founder and Chief Scientific Officer of MJ Research, and is currently an investor in over a dozen privately-held companies in biotechnology, alternative energy, and allied areas. He is a director of the privately-held companies Vaxart, Wavemark, Innerscope Research, Sage Science and Board Member at Banyan Energy, a director of the non-profit G Corp (administrator of the industry-leading AGBT Genomics meeting), and a past director of Mission Motors and Pharmasecure; he is also former Chief Executive Officer of Vaxart. Dr. Finney received his Ph.D. in Biology from the Massachusetts Institute of Technology, and was a Postdoctoral Fellow at Harvard Medical School/Massachusetts General Hospital. He holds eight U.S. patents.